IN172911B - - Google Patents

Info

Publication number
IN172911B
IN172911B IN57BO1991A IN172911B IN 172911 B IN172911 B IN 172911B IN 57BO1991 A IN57BO1991 A IN 57BO1991A IN 172911 B IN172911 B IN 172911B
Authority
IN
India
Prior art keywords
formulas
chem
image
novel compounds
antibiotic activity
Prior art date
Application number
Other languages
English (en)
Inventor
Christopher Milton Math Franco
Dilip Jatashankar Upadhyay
Louis Ernest Linus Coutinho
Bimal Naresh Dr Anguli
Juergen Dr Blumbach
Hans Wolferam Dr Fehlhaber
Original Assignee
Hoechst India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst India filed Critical Hoechst India
Priority to IN57BO1991 priority Critical patent/IN172911B/en
Priority to EP92107671A priority patent/EP0512522B1/fr
Priority to DK92107671.7T priority patent/DK0512522T3/da
Priority to ES92107671T priority patent/ES2079724T3/es
Priority to AT92107671T priority patent/ATE127806T1/de
Priority to DE69204733T priority patent/DE69204733T2/de
Priority to US07/879,398 priority patent/US5270182A/en
Priority to JP11507792A priority patent/JP3166126B2/ja
Publication of IN172911B publication Critical patent/IN172911B/en
Priority to GR950402849T priority patent/GR3017749T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/605—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin to a 1-benzopyran-2-on (or the chalcones and hydrogenated chalcones thereof, e.g. coumermycin, novobiocin, novenamin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IN57BO1991 1991-02-26 1991-02-26 IN172911B (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IN57BO1991 IN172911B (fr) 1991-02-26 1991-02-26
EP92107671A EP0512522B1 (fr) 1991-02-26 1992-05-06 Composés antibiotiques et leur production
DK92107671.7T DK0512522T3 (da) 1991-02-26 1992-05-06 Nye antibiotiske forbindelser og deres fremstilling
ES92107671T ES2079724T3 (es) 1991-02-26 1992-05-06 Nuevos compuestos antibioticos y su produccion.
AT92107671T ATE127806T1 (de) 1991-02-26 1992-05-06 Antibiotikverbindungen und ihre herstellung.
DE69204733T DE69204733T2 (de) 1991-02-26 1992-05-06 Antibiotikverbindungen und ihre Herstellung.
US07/879,398 US5270182A (en) 1991-02-26 1992-05-07 Antibiotic compounds and their production
JP11507792A JP3166126B2 (ja) 1991-02-26 1992-05-08 新規な抗生物質およびそれらの製造
GR950402849T GR3017749T3 (en) 1991-02-26 1995-10-16 Novel antibiotic compounds and their production.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN57BO1991 IN172911B (fr) 1991-02-26 1991-02-26
EP91107618 1991-05-10

Publications (1)

Publication Number Publication Date
IN172911B true IN172911B (fr) 1994-01-01

Family

ID=33454354

Family Applications (1)

Application Number Title Priority Date Filing Date
IN57BO1991 IN172911B (fr) 1991-02-26 1991-02-26

Country Status (9)

Country Link
US (1) US5270182A (fr)
EP (1) EP0512522B1 (fr)
JP (1) JP3166126B2 (fr)
AT (1) ATE127806T1 (fr)
DE (1) DE69204733T2 (fr)
DK (1) DK0512522T3 (fr)
ES (1) ES2079724T3 (fr)
GR (1) GR3017749T3 (fr)
IN (1) IN172911B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027010A1 (fr) * 2000-09-29 2002-04-04 Taisho Pharmaceutical Co., Ltd. Compose a base de xanthone
KR100474653B1 (ko) * 2004-04-16 2005-03-14 동국제약 주식회사 타이코플라닌의 고순도 생산방법
US20050271755A1 (en) * 2004-05-12 2005-12-08 Ilya Raskin Phytomedicinal compositions for the control of lipid accumulation and metabolism in mammals
KR102679066B1 (ko) * 2021-12-07 2024-06-27 한국해양과학기술원 항암효과가 우수한 신규 잔톤계 화합물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230692A (en) * 1978-11-03 1980-10-28 Ayerst Mckenna & Harrison, Inc. Ravidomycin and process of preparation
US4598145A (en) * 1982-08-16 1986-07-01 Bristol-Myers Company Albacarcins V and M
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
ATE72447T1 (de) * 1985-10-23 1992-02-15 Ishihara Sangyo Kaisha Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
JPS62207284A (ja) * 1986-03-07 1987-09-11 Rikagaku Kenkyusho 抗生物質ｒｋ−９５５ａ及びその製造法
DE68905578T2 (de) * 1988-12-09 1993-07-01 Kyowa Hakko Kogyo Kk Verbindung ks-505 und verfahren zur herstellung davon.

Also Published As

Publication number Publication date
JP3166126B2 (ja) 2001-05-14
JPH05155888A (ja) 1993-06-22
ATE127806T1 (de) 1995-09-15
GR3017749T3 (en) 1996-01-31
DK0512522T3 (da) 1996-01-29
EP0512522B1 (fr) 1995-09-13
DE69204733T2 (de) 1996-03-21
DE69204733D1 (de) 1995-10-19
US5270182A (en) 1993-12-14
ES2079724T3 (es) 1996-01-16
EP0512522A1 (fr) 1992-11-11

Similar Documents

Publication Publication Date Title
EP0563345A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
PH30007A (en) 7-(Substituted)-9-¬(sub-stituted glycyl)amido¾-6-dimethyl-6-deoxytetra-cyclines
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
AU8771591A (en) Retroviral protease inhibiting compounds
AU7820491A (en) Substituted Phthalides and Heterocyclic Phthalides and derivatives thereof.
AU2981792A (en) Piperazinyl-and piperidinyl-cyclohexanols
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
TW207533B (fr)
GR3007513T3 (fr)
GR3031781T3 (en) Antifungal sordaridin derivatives
TW223637B (fr)
JO1704B1 (en) New potent compounds
AU2623192A (en) Antifungal agent
AU6307586A (en) Quinoline derivatives
AU670121B2 (en) Antiretroviral acyl compounds
AP9400632A0 (en) Ether derivatives.
DK0521408T3 (fr)
AP8800109A0 (en) "Heterocyclic insecticides".
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
IN172911B (fr)
AU2186392A (en) Biological regulation of mineralization
EP0377127A3 (fr) Utilisation du Myricétine-3-O-bêta-D-glucuronide comme médicament
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
AU1368992A (en) Microbial transformation of recalcitrant pcb compounds